Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological Societies.
作者信息
Chapel H M
出版信息
Clin Exp Immunol. 1999 Oct;118 Suppl 1(Suppl 1):29-34. doi: 10.1046/j.1365-2249.1999.00000.x.
Abstract
摘要
相似文献
1
Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological Societies.免疫球蛋白替代疗法与潜在可传播病原体相关的安全性和可及性。国际免疫学会原发性免疫缺陷病委员会。国际免疫学会联盟。
Clin Exp Immunol. 1999 Oct;118 Suppl 1(Suppl 1):29-34. doi: 10.1046/j.1365-2249.1999.00000.x.
2
Blood safety and nucleic acid testing in Europe.欧洲的血液安全与核酸检测
Euro Surveill. 2005 Feb;10(2):3-4.
3
[Current applications of immunoglobulin therapy].[免疫球蛋白疗法的当前应用]
Fortschr Med. 1994 May 30;112(15):213-7.
4
5
Creutzfeldt-Jakob disease and blood products: FDA policy.克雅氏病与血液制品：美国食品药品监督管理局政策
Biologicals. 1998 Jun;26(2):133-4. doi: 10.1006/biol.1998.0131.
6
Variant Creutzfeldt-Jakob disease and prions in the blood supply.变异型克雅氏病与血液供应中的朊病毒
Clin Adv Hematol Oncol. 2004 Feb;2(2):84, 87, 131.
7
8
Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America.拉丁美洲原发性免疫缺陷患者使用人免疫球蛋白治疗的指南。
Allergol Immunopathol (Madr). 2014 May-Jun;42(3):245-60. doi: 10.1016/j.aller.2012.09.006. Epub 2013 Jan 18.
9
Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies.原发性免疫缺陷病。国际免疫学会科学委员会报告。国际免疫学会联盟。
Clin Exp Immunol. 1999 Oct;118 Suppl 1(Suppl 1):1-28. doi: 10.1046/j.1365-2249.1999.00109.x.
10
Management of primary antibody deficiency with replacement therapy: summary of guidelines.用替代疗法治疗原发性抗体缺陷：指南摘要
Immunol Allergy Clin North Am. 2008 Nov;28(4):875-6, x. doi: 10.1016/j.iac.2008.07.003.
引用本文的文献
1
Switching immunoglobulin products, what are the implications? Result of 2018 census of immunology centres.切换免疫球蛋白产品，有何影响？2018 年免疫学中心普查结果。
Clin Med (Lond). 2019 May;19(3):201-204. doi: 10.7861/clinmedicine.19-3-201.
2
Application of Antibody-Mediated Therapy for Treatment and Prevention of Infection.抗体介导疗法在感染治疗与预防中的应用。
Front Microbiol. 2018 Jun 25;9:1382. doi: 10.3389/fmicb.2018.01382. eCollection 2018.
3
Use of Polyclonal Intravenous Immunoglobulin at a Paediatric Referral Hospital in South Africa Between 2009 and 2012.2009年至2012年期间南非一家儿科转诊医院多克隆静脉注射免疫球蛋白的使用情况。
J Clin Immunol. 2015 Oct;35(7):668-74. doi: 10.1007/s10875-015-0192-y. Epub 2015 Sep 14.
4
Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol.西班牙医院中非特异性静脉用人免疫球蛋白的使用；需要制定医院方案。
Eur J Clin Pharmacol. 2010 Jun;66(6):633-41. doi: 10.1007/s00228-010-0800-y. Epub 2010 Mar 5.
5
Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.静脉注射免疫球蛋白：临床应用及作用机制的最新进展
J Clin Immunol. 2007 May;27(3):233-45. doi: 10.1007/s10875-007-9088-9. Epub 2007 Mar 11.
6
Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children.静脉注射免疫球蛋白治疗囊性纤维化肺病：16例儿童病例系列
Arch Dis Child. 2004 Apr;89(4):315-9. doi: 10.1136/adc.2003.026575.
7
Transverse sinus thrombosis and IVIg treatment: a case report and discussion of risk-benefit assessment for immunoglobulin treatment.横窦血栓形成与静脉注射免疫球蛋白治疗：一例病例报告及免疫球蛋白治疗的风险效益评估讨论
J Clin Pathol. 2003 Apr;56(4):308-9. doi: 10.1136/jcp.56.4.308.
8
Primary immunodeficiency diseases: an update.原发性免疫缺陷病：最新进展
Clin Exp Immunol. 2003 Apr;132(1):9-15. doi: 10.1046/j.1365-2249.2003.02110.x.
本文引用的文献
1
Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.血清和血浆蛋白的制备与性质；一种将生物组织和体液中的蛋白质和脂蛋白成分分离成各组分的系统。
J Am Chem Soc. 1946 Mar;68:459-75. doi: 10.1021/ja01207a034.
2
Deaths from variant Creutzfeldt-Jakob disease.变异型克雅氏病导致的死亡。
Lancet. 1999 Mar 20;353(9157):979. doi: 10.1016/s0140-6736(99)01160-5.
3
Retrospective neuropathological review of prion disease in UK haemophilic patients.英国血友病患者朊病毒病的回顾性神经病理学研究
Thromb Haemost. 1998 Dec;80(6):909-11.
4
PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service.
Biologicals. 1998 Jun;26(2):101-4. doi: 10.1006/biol.1998.0144.
5
Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease.变异型克雅氏病临床发病前阑尾中的朊病毒免疫反应性。
Lancet. 1998 Aug 29;352(9129):703-4. doi: 10.1016/S0140-6736(98)24035-9.
6
Shortage of intravenous immunoglobulin.静脉注射免疫球蛋白短缺。
Ann Allergy Asthma Immunol. 1998 Aug;81(2):97-100. doi: 10.1016/S1081-1206(10)62792-5.
7
Presence of a newly described human DNA virus (TTV) in patients with liver disease.一种新发现的人类DNA病毒（TTV）在肝病患者中的存在情况。
Lancet. 1998 Jul 18;352(9123):195-7. doi: 10.1016/S0140-6736(98)04069-0.
8
Detection of a novel DNA virus (TTV) in blood donors and blood products.在献血者和血液制品中检测到一种新型DNA病毒（TTV）。
Lancet. 1998 Jul 18;352(9123):191-5. doi: 10.1016/s0140-6736(98)03056-6.
9
Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: a comparison of apheresis and whole-blood donors. The Retrovirus Epidemiology Donor Study.人口统计学特征、未报告的风险行为以及病毒感染的患病率和发病率：单采血液成分献血者与全血献血者的比较。逆转录病毒流行病学献血者研究。
Transfusion. 1998 Apr;38(4):350-8. doi: 10.1046/j.1537-2995.1998.38498257373.x.
10
Hepatitis G virus infection before and after liver transplantation. Liver Transplantation Database.肝移植前后的庚型肝炎病毒感染。肝移植数据库。
Liver Transpl Surg. 1997 Nov;3(6):578-85. doi: 10.1002/lt.500030604.
Zotero 插件